Logo
x

Search

Subscribe Now

Cancer

AbbVie to Acquire ImmunoGen for $10.1B

AbbVie to Acquire ImmunoGen for $10.1B

  • December 1, 2023
Biosimilar Solutions Reports the Initiation of Registrational Clinical Trials for Biosimilar BSC0826 to Treat Cancer

Biosimilar Solutions Reports the Initiation of Registrational Clinical Trials for Biosimilar BSC0826 to Treat Cancer

  • April 13, 2022
Regeneron Entered into a License Agreement with Nykode to Develop Vaccines Against Cancer and Infectious Diseases

Regeneron Entered into a License Agreement with Nykode to Develop Vaccines Against Cancer and Infectious Diseases

  • November 23, 2021
CStone Signs an Exclusive License Agreement with Jiangsu Hengrui to Develop and Commercialize CS1002 in Greater China

CStone Signs an Exclusive License Agreement with Jiangsu Hengrui to Develop and Commercialize CS1002 in Greater China

  • November 22, 2021
Innovent Entered into a Collaboration Agreement with NeoCura to Evaluate Sintilimab + NEO_PLIN2101 for Cancer in China

Innovent Entered into a Collaboration Agreement with NeoCura to Evaluate Sintilimab + NEO_PLIN2101 for Cancer in China

  • October 28, 2021
Genentech Signs a License Agreement with Adaptimmune to Develop and Commercialize Cancer-Targeted Allogeneic T-cell Therapies

Genentech Signs a License Agreement with Adaptimmune to Develop and Commercialize Cancer-Targeted Allogeneic T-cell Therapies

  • September 8, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.